Cost Effectiveness of Warfarin Versus Aspirin in Patients Older Than 75 Years With Atrial Fibrillation | Zendy

Sue Jowett | Zendy; Stirling Bryan | Zendy; Jonathan Mant | Zendy; Kate Fletcher | Zendy; Andrea Roalfe | Zendy; David Fitzmaurice | Zendy; Gregory Y.H. Lip | Zendy; Richard Hobbs | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Cost Effectiveness of Warfarin Versus Aspirin in Patients Older Than 75 Years With Atrial Fibrillation

Author(s) -

Sue Jowett,

Stirling Bryan,

Jonathan Mant,

Kate Fletcher,

Andrea Roalfe,

David Fitzmaurice,

Gregory Y.H. Lip,

Richard Hobbs

Publication year - 2011

Publication title -

stroke

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.397

H-Index - 319

eISSN - 1524-4628

pISSN - 0039-2499

DOI - 10.1161/strokeaha.110.600767

Subject(s) - medicine , warfarin , atrial fibrillation , aspirin , stroke (engine) , population , randomized controlled trial , quality of life (healthcare) , cost effectiveness , quality adjusted life year , anticoagulant , emergency medicine , cardiology , mechanical engineering , risk analysis (engineering) , nursing , environmental health , engineering

Oral anticoagulants are effective at reducing stroke compared with aspirin in atrial fibrillation patients older than 75 years. Although the benefits of reduced stroke risk outweigh the risks of bleeding, the cost effectiveness of warfarin in this patient population has not yet been established.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research